7TM Pharma Has Initiated Phase I/IIa Clinical Trial with TM30339

September 2, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

7TM Pharma today announced that it has initiated a Phase I/IIa clinical trial with the drug candidate TM30339, which was discovered internally at 7TM Pharma and is being developed for treatment of obesity and related metabolic disorders.

Twitter
LinkedIn
Facebook
Email
Print

Clinical research Phase 2